Medicamen Organics Limited Share Price & Stock Analysis

Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products under the LOIRE brand. The company markets its products to government and private institutions as contract manufacturer/third party manufacturer; and private pharmaceutical companies through third party distributors or on loan license basis across India; African, CIS, and Southeast Asian Countries; and internationally. Medicamen Organics Limited was formerly known as Panchdeep Pharmaceuticals Limited and changed its name to Medicamen Organics Limited

Key Metrics

Current Price₹22.25
Market Cap₹27 Cr
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Contract Manufacturing Services; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Cardiovascular Drugs; Generic Pharmaceuticals
P/E Ratio-6.5
Beta (1Y)1.15

Frequently Asked Questions

What is the current share price of Medicamen Organics Limited?

Medicamen Organics Limited is trading at ₹22.25, with a market capitalisation of ₹27 Cr.

Which sector does Medicamen Organics Limited belong to?

Medicamen Organics Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Contract Manufacturing Services; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Cardiovascular Drugs; Generic Pharmaceuticals).

What are the key financial ratios of Medicamen Organics Limited?

Medicamen Organics Limited has a P/E of -6.5.